loading
Schlusskurs vom Vortag:
$12.03
Offen:
$12.1
24-Stunden-Volumen:
7.13M
Relative Volume:
1.53
Marktkapitalisierung:
$5.92B
Einnahmen:
$4.45B
Nettoeinkommen (Verlust:
$205.00M
KGV:
29.93
EPS:
0.4
Netto-Cashflow:
$372.00M
1W Leistung:
-4.01%
1M Leistung:
+0.42%
6M Leistung:
-3.86%
1J Leistung:
-25.28%
1-Tages-Spanne:
Value
$11.88
$12.14
1-Wochen-Bereich:
Value
$11.39
$12.47
52-Wochen-Spanne:
Value
$11.11
$18.80

Elanco Animal Health Inc Stock (ELAN) Company Profile

Name
Firmenname
Elanco Animal Health Inc
Name
Telefon
877-352-6261
Name
Adresse
2500 INNOVATION WAY, GREENFIELD
Name
Mitarbeiter
9,800
Name
Twitter
@Elanco
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
ELAN's Discussions on Twitter

Vergleichen Sie ELAN mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - Specialty & Generic icon
ELAN
Elanco Animal Health Inc
11.97 5.92B 4.45B 205.00M 372.00M 0.40
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
174.12 78.56B 9.15B 2.43B 2.31B 5.32
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.61 43.15B 30.25B 1.37B 5.08B 0.4257
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.51 43.00B 14.26B 1.55B 0 0.3383
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
17.29 19.59B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
NBIX
Neurocrine Biosciences Inc
150.51 15.24B 2.24B 385.90M 440.10M 3.73

Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-12-09 Eingeleitet UBS Buy
2024-12-02 Eingeleitet Leerink Partners Market Perform
2024-09-19 Herabstufung Morgan Stanley Overweight → Equal-Weight
2024-01-05 Hochstufung Stifel Hold → Buy
2023-12-19 Eingeleitet Jefferies Buy
2023-12-15 Hochstufung Morgan Stanley Equal-Weight → Overweight
2023-12-07 Eingeleitet Exane BNP Paribas Outperform
2023-04-20 Hochstufung Barclays Equal Weight → Overweight
2022-08-18 Herabstufung Morgan Stanley Overweight → Equal-Weight
2022-08-16 Herabstufung JP Morgan Overweight → Neutral
2022-07-21 Herabstufung Goldman Buy → Sell
2022-07-12 Eingeleitet Piper Sandler Neutral
2021-11-18 Eingeleitet Morgan Stanley Overweight
2021-10-28 Herabstufung Stifel Buy → Hold
2021-08-05 Fortgesetzt Credit Suisse Outperform
2021-06-15 Hochstufung Cleveland Research Underperform → Neutral
2021-05-11 Hochstufung Barclays Underweight → Equal Weight
2021-05-11 Hochstufung Gabelli & Co Hold → Buy
2021-04-15 Eingeleitet Stifel Buy
2021-03-22 Herabstufung Gabelli & Co Buy → Hold
2021-02-26 Hochstufung Credit Suisse Neutral → Outperform
2020-12-09 Herabstufung Argus Buy → Hold
2020-11-09 Herabstufung Barclays Overweight → Underweight
2020-08-20 Hochstufung Morgan Stanley Equal-Weight → Overweight
2020-08-13 Fortgesetzt Credit Suisse Neutral
2020-08-04 Fortgesetzt Goldman Buy
2020-07-27 Herabstufung Cleveland Research Neutral → Underperform
2020-04-02 Herabstufung Morgan Stanley Overweight → Equal-Weight
2020-01-10 Eingeleitet Raymond James Mkt Perform
2019-12-19 Hochstufung BofA/Merrill Neutral → Buy
2019-11-07 Hochstufung Morgan Stanley Equal-Weight → Overweight
2019-09-23 Eingeleitet Barclays Overweight
2019-08-26 Herabstufung BofA/Merrill Buy → Neutral
2019-08-15 Hochstufung UBS Sell → Neutral
2019-05-23 Eingeleitet Guggenheim Neutral
2019-03-18 Hochstufung BofA/Merrill Neutral → Buy
2019-03-13 Fortgesetzt Morgan Stanley Equal-Weight
2019-02-12 Eingeleitet William Blair Mkt Perform
2019-01-23 Eingeleitet UBS Sell
2019-01-15 Eingeleitet Argus Buy
2018-10-15 Eingeleitet Morgan Stanley Equal-Weight
Alle ansehen

Elanco Animal Health Inc Aktie (ELAN) Neueste Nachrichten

pulisher
04:15 AM

Veterinary Eye Care Market to Grow by USD 1.05 Billion(2024-2028), Boosted by Rising Pet Ownership & Market Transformation Driven by AITechnavio - Yahoo Finance

04:15 AM
pulisher
Feb 06, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elanco Animal Health Incorporated (ELAN) and Encourages Investors to Learn More About the Investigation - Markets Insider

Feb 06, 2025
pulisher
Feb 06, 2025

Veterinary Wound Cleansers Market Share & Growth Forecast Report 2025-2030, with Elanco, Vetoquinol, Virbac, Innovacyn, Axio Biosolutions, Neogen, Pet Natural Remedies, Zoetis and More - Yahoo Finance UK

Feb 06, 2025
pulisher
Feb 06, 2025

Private Management Group Inc. Acquires 914,808 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat

Feb 06, 2025
pulisher
Feb 06, 2025

Animal Parasiticides Market Witness Growth: Size, Share, - openPR

Feb 06, 2025
pulisher
Feb 05, 2025

Elanco Launches Pradalex for Treatment of Livestock Respiratory Diseases - Drovers Magazine

Feb 05, 2025
pulisher
Feb 05, 2025

Elanco Animal Health Incorporated (ELAN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - Markets Insider

Feb 05, 2025
pulisher
Feb 05, 2025

BlackRock, Inc.'s Strategic Acquisition of Elanco Animal Health Inc Shares - GuruFocus.com

Feb 05, 2025
pulisher
Feb 05, 2025

Elanco launches novel treatment for livestock respiratory diseases - Feedstuffs

Feb 05, 2025
pulisher
Feb 05, 2025

Pet Pharmaceuticals Market Growth to Accelerate in Forecast - openPR

Feb 05, 2025
pulisher
Feb 04, 2025

Elanco Animal Health Incorporated (NYSE:ELAN) Shares Acquired by KBC Group NV - MarketBeat

Feb 04, 2025
pulisher
Feb 04, 2025

Elanco Confirms Date and Conference Call for Fourth Quarter and Full Year 2024 Financial Results Announcement - Nasdaq

Feb 04, 2025
pulisher
Feb 03, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Elanco Animal Health Incorporated (ELAN) And Encourages Stockholders to Connect - Markets Insider

Feb 03, 2025
pulisher
Feb 03, 2025

Jim Cramer on Elanco Animal Health Incorporated (ELAN): ‘Not My Favorite’ - Insider Monkey

Feb 03, 2025
pulisher
Feb 02, 2025

Elanco Animal Health (NYSE:ELAN) Given New $14.00 Price Target at Morgan Stanley - MarketBeat

Feb 02, 2025
pulisher
Feb 01, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elanco Animal Health Incorporated (ELAN) and Encourages Stockholders to Learn More About the Investigation - Markets Insider

Feb 01, 2025
pulisher
Jan 30, 2025

Elanco Animal demitasse Health Incorporated - The Branding Iron

Jan 30, 2025
pulisher
Jan 30, 2025

US FDA approves Elanco's treatment for parasitic infections in dogs - AOL

Jan 30, 2025
pulisher
Jan 30, 2025

Veterinary Medicine Market Is Booming Worldwide 2025-2032 | - openPR

Jan 30, 2025
pulisher
Jan 29, 2025

Elanco price target lowered to $14 from $15 at Morgan Stanley - MSN

Jan 29, 2025
pulisher
Jan 29, 2025

2025-01-29 | Bronstein, Gewirtz & Grossman, LLC Encourages Elanco Animal Health Incorporated (ELAN) Shareholders to Inquire about Securities Investigation | NYSE:ELAN | Press Release - Stockhouse Publishing

Jan 29, 2025
pulisher
Jan 28, 2025

ELAN SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Elanco Animal Health Incorporated and Urges Investors to Contact the Firm Today! - ACCESS Newswire

Jan 28, 2025
pulisher
Jan 27, 2025

Meet the Faces of Zen: Elanco's Zenrelia™ (ilunocitinib tablets) Helps Allergic Dogs Get Back to Normal - PR Newswire

Jan 27, 2025
pulisher
Jan 26, 2025

2025-01-26 | Bronstein, Gewirtz & Grossman, LLC Is Investigating Elanco Animal Health Incorporated (ELAN) And Encourages Shareholders to Connect | NYSE:ELAN | Press Release - Stockhouse Publishing

Jan 26, 2025
pulisher
Jan 24, 2025

Senior, geriatric dog care focus of new industry partnership - VeterinaryPracticeNews.com

Jan 24, 2025
pulisher
Jan 24, 2025

Animal Gastroesophageal Reflux Disease Market Analysis Report 2025-2030, with Profiles of Key Players Zoetis, Merck, Elanco, Ceva, BioZyme, Annamaet Petfoods, Hill's Pet Nutrition, Blue Buffalo & More - Yahoo Finance

Jan 24, 2025
pulisher
Jan 23, 2025

Now Available: Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Provides Broadest[i] Parasite Protection of Its Kind - PR Newswire

Jan 23, 2025
pulisher
Jan 23, 2025

Assenagon Asset Management S.A. Sells 1,369,833 Shares of Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat

Jan 23, 2025
pulisher
Jan 22, 2025

2025-01-22 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Elanco Animal Health Incorporated (ELAN) And Encourages Shareholders to Reach Out | NYSE:ELAN | Press Release - Stockhouse Publishing

Jan 22, 2025
pulisher
Jan 22, 2025

Jim Cramer: AMD Is A 'Great' Company, Hold Onto Dow Inc. - Benzinga

Jan 22, 2025
pulisher
Jan 21, 2025

UK Veterinary Medicine Market May See a Big Move | Norbrook, Merck, Elanco - openPR

Jan 21, 2025
pulisher
Jan 21, 2025

Is Elanco Animal Health Incorporated (ELAN) the Most Undervalued Stock to Invest in for Under $20? - Insider Monkey

Jan 21, 2025
pulisher
Jan 20, 2025

12 Most Undervalued Stocks to Invest in for Under $20 - Insider Monkey

Jan 20, 2025
pulisher
Jan 20, 2025

Top animal health companies by revenue worldwide 2023 - Statista

Jan 20, 2025
pulisher
Jan 19, 2025

2025-01-19 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elanco Animal Health Incorporated (ELAN) and Encourages Investors to Learn More About the Investigation | NYSE:ELAN | Press Release - Stockhouse Publishing

Jan 19, 2025
pulisher
Jan 18, 2025

ELAN (Elanco Animal Health) Deferred Tax : $0 Mil (TTM As of Sep. 2024) - GuruFocus.com

Jan 18, 2025
pulisher
Jan 17, 2025

Elanco Animal Health's SWOT analysis: stock outlook amid product challenges - MSN

Jan 17, 2025
pulisher
Jan 17, 2025

ELAN (Elanco Animal Health) Long-Term Debt : $4,313 Mil (As of Sep. 2024) - GuruFocus.com

Jan 17, 2025
pulisher
Jan 16, 2025

Elanco Animal Health’s SWOT analysis: stock outlook amid product challenges - Investing.com Nigeria

Jan 16, 2025
pulisher
Jan 16, 2025

Companion Animal Ear Infection Treatment Market SWOT Analysis by Leading Expert: Elanco, Vetoquinol, Ceva - openPR

Jan 16, 2025
pulisher
Jan 15, 2025

2025-01-15 | Elanco Animal Health Incorporated (ELAN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | NYSE:ELAN | Press Release - Stockhouse Publishing

Jan 15, 2025
pulisher
Jan 15, 2025

Elanco Animal Health: Building On Success (NYSE:ELAN) - Seeking Alpha

Jan 15, 2025
pulisher
Jan 15, 2025

Veterinary Vaccines Market SWOT Analysis by Leading Expert: Virbac, Elanco, HIPRA - openPR

Jan 15, 2025
pulisher
Jan 14, 2025

ELAN (Elanco Animal Health) Change In Working Capital : $239 Mil (TTM As of Sep. 2024) - GuruFocus.com

Jan 14, 2025
pulisher
Jan 12, 2025

2025-01-12 | Bronstein, Gewirtz & Grossman, LLC Is Investigating Elanco Animal Health Incorporated (ELAN) And Encourages Investors to Connect | NYSE:ELAN | Press Release - Stockhouse Publishing

Jan 12, 2025
pulisher
Jan 12, 2025

Is Elanco Animal Health (ELAN) the Best Medical Stock to Buy Under $20? - Insider Monkey

Jan 12, 2025
pulisher
Jan 11, 2025

12 Best Medical Stocks To Buy Under $20 - Insider Monkey

Jan 11, 2025

Finanzdaten der Elanco Animal Health Inc-Aktie (ELAN)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$90.90
price up icon 0.51%
$31.39
price down icon 0.25%
$10.90
price down icon 0.46%
$127.12
price up icon 0.07%
$150.51
price down icon 0.46%
Kapitalisierung:     |  Volumen (24h):